| Ryan Carter, MD | |
|
593 Eddy St, Providence, RI 02903-4923 | |
| (401) 519-1604 | |
| (401) 272-0538 |
| Full Name | Ryan Carter |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720254006 | NPI | - | NPPES |
| 10/27/2009 | Other | MA | TUFTS HEALTH PLAN |
| RC76597 | Medicaid | RI | |
| 11/02/2009 | Other | RI | BCBS |
| 110082578A | Medicaid | MA | |
| 939025129 | Other | RI | UEMF RI MEDICARE GROUP |
| 04/15/2009 | Other | RI | UNITED HEALTHCARE |
| 1962455022 | Other | RI | UEMF GROUP NPI |
| 011211701 | Other | RI | RI MEDICARE |
| 09/10/2009 | Other | RI | NHPRI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Landmark Medical Center | Woonsocket, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Associates Of Woonsocket Llc | 6002050648 | 11 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
| Entity Name | Emergency Associates Of Woonsocket Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912342528 PECOS PAC ID: 6002050648 Enrollment ID: O20130920000246 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
| Entity Name | Emergency Care Services Of New England Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639537335 PECOS PAC ID: 9739487562 Enrollment ID: O20160412001747 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
| Entity Name | Lmw Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447595368 PECOS PAC ID: 7012155112 Enrollment ID: O20190520001320 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
| Entity Name | Physicians At Landmark |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255038212 PECOS PAC ID: 4688039084 Enrollment ID: O20230508000159 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Carter, MD 20 York Street, Cb-2041, New Haven, CT 06510-3220 Ph: (203) 688-1734 | Ryan Carter, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 519-1604 |
News Archive
Results from a New Zealand study show that vitamin D deficiency is common in psychiatric inpatients, particularly among patients with schizophrenia and those of Maori descent.
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The Food Marketing Institute (FMI) and GS1 US today announced the launch of Rapid Recall Exchange, an online service to enable prompt and accurate information exchange between retailers/wholesalers and suppliers about food and product recalls and withdrawals. It replaces an existing recall system, the Product Recall Portal, by improving ease of use and adding significant capabilities.
Cardiome Pharma Corp. today announced that its Chinese development and commercialization partner, Eddingpharm, plans to initiate a Phase 1 study for BRINAVESSTM to support regulatory approval in China. The study will be conducted in healthy volunteers.
› Verified 1 days ago
Dr. Robert A Partridge, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-519-1604 Fax: 401-272-0538 | |
Dr. Gregory R Lockhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-444-4000 Fax: 401-427-7795 | |
Ian M Jacobson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 330-493-4443 | |
Dr. Daniel Shanin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Carli Renske Reisdorf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6680 | |
Dr. Oriane Diana Longerstaey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 704-355-3181 | |
Rachel Smith Shain, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6489 Fax: 401-444-6662 |